Table of Contents
This report includes an analysis of the growing use of HTA in emerging market countries and its impact on pricing, reimbursement, and market access Drivers and resistors to use of HTA in emerging markets are discussed, as well as the different ways in which HTA has been implemented in key emerging markets so far
Features and benefits
Understand key trends in HTA development and use in emerging markets
Gain insight into how HTA is impacting access in emerging markets
Visualize where HTA fits in the pricing and reimbursement process in key emerging markets and its impact on decision-making
A discussion of the drivers and resistors of HTA use, as well as an overview of the different ways in which HTA has been implemented thus far in key emerging markets
Detailed analysis of HTA processes and their impact on pricing and reimbursement in Brazil, China, Mexico, Poland, South Korea, and Taiwan
An analysis of how pharma companies’ strategies are changing in order to engage a new group of stakeholders
Your key questions answered
What are the differences between HTA use in different emerging market countries?
How have pharma’s strategies adapted in reaction to the changes brought about by HTA?
What channels exist for pharma-HTA engagement?
What are the key lessons for success in overcoming hurdles presented by HTA in emerging markets?
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
The global healthcare IT market is expected to grow at a CAGR of 15.9% from 2016 to 2021 and reach USD 280.25 billion. Growing need to manage regulatory compliance through healthcare IT solutions, government ...
Digital transformation helps enterprises improve operational performance, efficiency, and business process. It involves the utilization of digital technologies, such as mobility, analytics, and social ...
The ultrasound market is expected to reach USD 6.86 billion by 2021 at a CAGR of 5.2% during 2016-2021. North America and Europe held the largest share of the market in 2016; however, the Asia-Pacific ...